More stories

  • in

    First Once-Weekly Basal Insulin Approved for Type 2 Diabetes

    Source link : https://newshealth.biz/health-news/first-once-weekly-basal-insulin-approved-for-type-2-diabetes/ The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency rejected the product in 2024 for type 1 diabetes, where it is still not indicated. Designed to reduce treatment burden as an alternative to daily […] […] More

  • in

    CDC Report Spots Decreasing Coverage of 5 Vaccines

    Source link : https://newshealth.biz/health-news/cdc-report-spots-decreasing-coverage-of-5-vaccines/ Vaccine coverage by age 2 was similar between kids born in 2021-2022 and 2019-2020, a CDC report showed. However, decreases were observed for five vaccines and in certain demographic groups for kids born in 2021-2022. These data precede the CDC’s drastic reduction in the number of universally recommended childhood vaccines, and the impact of this […] […] More

  • in

    Lancet Retracts 1977 Commentary; Predicting Liver Cancer; Genetic Testing Fraud

    Source link : https://newshealth.biz/health-news/lancet-retracts-1977-commentary-predicting-liver-cancer-genetic-testing-fraud/ A 49-year-old unsigned commentary in The Lancet that’s been used in litigation to prop up the safety of talc products has been retracted after it was revealed the author was a paid consultant to Johnson & Johnson at the time it was written. (Retraction Watch) Researchers are now able to identify why some veterans exposed […] […] More

  • in

    Brain Disease Decades Later? Study Links Childhood Surgery to Amyloid Build-Up

    Source link : https://newshealth.biz/health-news/brain-disease-decades-later-study-links-childhood-surgery-to-amyloid-build-up/ Evidence of iatrogenic beta-amyloid transmission was identified in two patients who developed early-onset cerebral amyloid angiopathy decades after undergoing pediatric cardiac surgery. The findings suggest that the use of cadaveric dura mater patches in cardiac surgery seeded amyloid pathology, leading to neurovascular complications 40 years later, noted Jean-Baptiste Brunet de Courssou, MD, MSc, of University […] […] More

  • in

    ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

    Source link : https://newshealth.biz/health-news/ici-related-toxicity-diagnoses-differ-for-dark-vs-light-skin/ A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in patients with skin of color vs lighter skin tones. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ici-related-toxicity-diagnoses-differ-dark-vs-light-skin-2026a10009hd?src=rss Author : Publish date : 2026-03-27 17:49:00 Copyright for syndicated content belongs to the linked Source. The post ICI-Related Toxicity Diagnoses Differ […] More

  • in

    AI data centres can warm surrounding areas by up to 9.1°C

    Source link : https://newshealth.biz/health-news/ai-data-centres-can-warm-surrounding-areas-by-up-to-9-1c/ The number of data centres is rapidly increasing JIM LO SCALZO/EPA/Shutterstock Data centres built to power AIs produce so much heat that they can raise the surface temperature of the land around them by several degrees – creating so-called data centre heat islands that may already be affecting up to 340 million people. The number […] […] More

  • in

    He Suddenly Couldn’t Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

    Source link : https://newshealth.biz/health-news/he-suddenly-couldnt-speak-in-space-astronaut-says-medical-scare-remains-a-mystery/ The astronaut who prompted NASA’s first medical evacuation earlier this year said Friday that doctors still don’t know why he suddenly fell sick at the International Space Station. Four-time space flier Mike Fincke said he was eating dinner on Jan. 7 after prepping for a spacewalk the next day when it happened. He couldn’t talk […] […] More

  • in

    Union Staff Strike at BMA Over Pay

    Source link : https://newshealth.biz/health-news/union-staff-strike-at-bma-over-pay/ Hundreds of BMA staff strike over pay, with unions warning real-terms cuts have left morale at ‘rock bottom’. Press Association Source link : https://www.medscape.com/s/viewarticle/union-staff-strike-bma-over-pay-2026a10009fk?src=rss Author : Publish date : 2026-03-27 17:52:00 Copyright for syndicated content belongs to the linked Source. The post Union Staff Strike at BMA Over Pay first appeared on News Health. —- Author […] More

  • in

    Tried-and-True Carpal Tunnel Treatment Flops in Controlled Trial

    Source link : https://newshealth.biz/health-news/tried-and-true-carpal-tunnel-treatment-flops-in-controlled-trial/ Wrist splinting is widely used as a conservative treatment for carpal tunnel syndrome, but rigorous evidence for its effectiveness is scant. This trial randomized 142 patients to wear a rigid splint or a soft “placebo” bandage, with a composite symptom score at 12 weeks and progression to surgery within 1 year as co-primary outcomes. Symptom […] […] More

  • in

    FDA OKs Therapy for Deadly Pediatric Immune Disorder

    Source link : https://newshealth.biz/health-news/fda-oks-therapy-for-deadly-pediatric-immune-disorder/ The FDA on Thursday granted accelerated approval to marnetegragene autotemcel (Kresladi) as the first gene therapy for treating kids with severe leukocyte adhesion deficiency type I (LAD-I), an ultra-rare inherited immune deficiency. Approval stipulates use in LAD-I cases caused by biallelic variants in the ITGB2 gene and in which no human leukocyte antigen (HLA)-matched sibling […] […] More

  • in

    What to Expect for Prior Authorization in 2026

    Source link : https://newshealth.biz/health-news/what-to-expect-for-prior-authorization-in-2026/ Prior authorization requirements cost the U.S. healthcare system an estimated $35 billion each year, and their overuse has triggered a backlash, stirring some policymakers into action. Whether these changes actually fix prior authorization for patients and clinicians is an open question. Meanwhile, stakeholders are weighing the risks versus benefits of artificial intelligence (AI) to streamline […] […] More

  • in

    EMA Backs Orodispersible Furosemide for Edema in Children

    Source link : https://newshealth.biz/health-news/ema-backs-orodispersible-furosemide-for-edema-in-children/ The European regulator recommends granting pediatric use marketing authorization for Bopediat to treat children with oedema and hypertension from chronic kidney disease. Medscape News Europe Source link : https://www.medscape.com/viewarticle/ema-backs-orodispersible-furosemide-edema-children-2026a10009h7?src=rss Author : Publish date : 2026-03-27 16:42:00 Copyright for syndicated content belongs to the linked Source. The post EMA Backs Orodispersible Furosemide for Edema in Children first […] More

Load More
Congratulations. You've reached the end of the internet.